Rolf Westerberg

Rolf Westerberg is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as Senior Director of Program and Alliance Management at Calliditas Therapeutics since November 2025. Previously, Rolf held key positions including Senior Project and Portfolio Manager at Orexo AB and Director of Clinical Development/Global Project Manager at Affibody AB. Rolf's extensive experience includes managing pre-clinical and clinical projects at Moberg Pharma and serving as a Study Director and Toxicology Project Leader at AstraZeneca. Rolf's academic background comprises a Ph.D. in Physiology and Molecular and Cellular Biology from Stockholm University, along with a Master of Science in Embryonic Stem Cells from the Institute of Molecular and Cell Biology in Singapore.